JDRF Continues to Lead with T1D Research From Vaccines to Smart Insulin

Between their partnership with Selecta for a T1D vaccine as referenced below and their partnership with Smartcells on “Smart Insulin”, the JDRF is coming at the issue of T1D from many angles. These developments are still years away (although Smart Insulin is expected to go to human trials soon), for us parents, it is comforting to know that technology is in the works that will likely alter the way our children will deal with T1D as adults.

JDRF has partnered with Selecta to develop a novel technology for creating a T1D vaccine to potentially halt the Disease Process. Click here to  Read More…

JDRF has partnered with Smart Cells on the development of Smart Insulin.  Smart insulin is a form of insulin that circulates in the bloodstream and turns on when it’s needed to lower blood sugars and off when blood sugars are at safe levels.  See the JDRF Smart Insulin Video Below or click here to Read More..